Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles
- 1 certified filing for “Associate Director - Global Regulatory Affairs, Oncology” (Regulatory Affairs Managers) in WA: $154k–$154k, median $154k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and those who can benefit from PrEP. ViiV is highly mission-driven in our unrelenting commitment to being a trusted partner for all people living with and affected by HIV. Our aim is to think, act, and connect differently through a focus on HIV prevention, treatment and cure. We go to extraordinary lengths to deliver the sorts of breakthroughs, both in treatments, care solutions and communities, that really count. We go beyond the boundaries of medicine by taking a holistic approach to HIV through developing and supporting sustainable community programs and improving access to care. We are fully committed to push through every challenge until HIV is eradicated. ViiV has played a significant part in delivering breakthroughs that have turned HIV into a manageable health condition. We offer the largest portfolio of HIV medicines available anywhere, and we continue our work to cater for the widest possible range of needs in response to the HIV epidemic.
We are aware of how much is at stake for those living with and affected by HIV and we show up every day 100% committed to people living with HIV and those who can benefit from PrEP. Our work culture is fast-paced, diverse, inclusive, competitive, and caring. But ViiV isn’t just somewhere to work – it’s a place to belong, an invitation to bring your very best, and a team full of impact-driven team members who are hungry to make a difference.
While we have been improving lives of people living with HIV for 30 years, this is an especially exciting time to be at ViiV, as we evaluate novel approaches to treatment prevention, and cure that could further reduce the impact of HIV on individuals and communities.
The Global Patient Engagement Director (US) leads the development and execution of ViiV Healthcare’s patient engagement strategy across the US, ensuring that the voices, experiences and priorities of people living with HIV, communities disproportionately affected by HIV, and those who may benefit from HIV prevention are systematically integrated into business decision-making.
The role acts as a critical bridge between ViiV’s global patient engagement strategy and regional execution, adapting global priorities to diverse local market contexts while ensuring patient, community and healthcare system insights from the region inform global strategy, capability building and decision-making.
The role is responsible for generating, translating and embedding patient and community insights across the medicine lifecycle, from clinical development and evidence generation through to access, uptake and long-term patient outcomes. Working in partnership with patients, community organisations, advocacy leaders, healthcare professionals and internal stakeholders, the Director drives an insight-to-action approach that informs strategy, strengthens patient-centred innovation and advances ViiV’s mission to leave no person living with HIV behind.
As the patient engagement lead, the role works in close partnership with US External Affairs and R&D as a priority, while also collaborating across Medical, Commercial, Market Access and Government Affairs to ensure patient and community perspectives shape key decisions, programmes and priorities. The Director champions meaningful engagement, fosters trusted community partnerships, builds organisational capability in patient-centricity, and demonstrates the impact of patient engagement on business, healthcare and community outcomes across diverse markets.
The Director advances co-creation strengthens ViiV's leadership within the HIV community and supports the company's commitment to leave no person l
Apply on employer site ↗